On September 1, 2022, Health Canada authorized the use of Moderna Spikevax Bivalent (50 mcg) COVID-19 vaccine as a booster dose in adults aged 18 years of age and older. This represents the first bivalent Omicron (BA.1)-containing mRNA COVID-19 vaccine authorized for use in Canada.